Evidence of immune involvement in AMD [10] has led to the development of a mouse model knockout of monocyte chemoattractant protein-1 (MCP-1/CCL2) or its cognate chemokine receptor (CCR2) [11]. Here, CCL2 is linked to age-related macular degeneration.